Form 4: Jazz Pharmaceuticals SVP Sells Shares to Cover Tax Obligations
SEC Form 4
Mary Elizabeth Henderson, SVP of Technical Operations at Jazz Pharmaceuticals, sold 1,410 ordinary shares to cover tax obligations arising from vested restricted stock units.
Summary
- On September 6, 2024, Mary Elizabeth Henderson, SVP of Technical Operations at Jazz Pharmaceuticals, sold 1,410 ordinary shares of the company.
- The shares were sold at a price of $108.3 per share.
- The sale was executed to satisfy tax obligations related to the vesting of previously granted restricted stock units.
- Following the transaction, Henderson directly owns 14,531 ordinary shares of Jazz Pharmaceuticals.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (sale of shares to cover tax obligations). It doesn't indicate any significant positive or negative sentiment.
Industry Context
Sales of shares by company executives are a normal part of executive compensation and financial planning. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.
Stakeholder Impact
- The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to have a significant impact.
Key Dates
| Date | Description |
|---|---|
| 09/06/2024 | Date of the share sale transaction. |
| 09/11/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.